Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Zenabis Global Inc. T.ZENA

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
We are a diverse, passionate team of doctors, scientists, researchers, growers, educators, and advocates who came together with the goal of increasing access to safe, high quality cannabis for medical patients and recreational consumers. Our four facilities are located coast-to-coast across Canada in Delta and Langley, British Columbia; Atholville, New Brunswick; and Stellarton, Nova Scotia. Zenabis currently owns 3.5 million square feet of facility space.


TSX:ZENA - Post by User

Zenabis Global Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Post by Jimmy713on Feb 09, 2021 7:34am
128 Views
Post# 32510387

CONS/PROS By end of 2020

CONS/PROS By end of 2020MY view of where we standing at end of 2020, please add/correct/comment at your convenient
  • Expected in Q4: Higher revenues
  • Interest Rate: Interest rate on Secured debenture of $51.5M decreased from 14% to 10%
  • Merger/Acquisition: Announcement of a potential merger on Jan 6th
  • Sales: Proven growth each quarter, excellent well known products (Namaste & Re-up)
  • Production: high production of 111k kg at a low cost of 0.76 per gram
  • Debt: Refinanced until 2022 & decreased by 54% from a year ago, total debt 65M
  • Shorts: potentially high percentage of shorts
  • Cash: $5M & available $10M  
  • Outstanding & warrants: fully diluted 1.25B shares
By last quarter of 2019, the stock price dropped to below $1, during 2020 we witnessed a high of only 21 cents and a low of 4.5 cents majorly by SNDL manipulations, lets all welcome 2021 and go back to our position north of $1.

Good luck to all long 
 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities